Implantable drug delivery systems (IDDS) are long term acting controlled release systems.

植入型给药系统适用于长期给药和靶向给药。

youdao

The FDA comes up with another safety question that must be resolved, the same way it got worried about the long-acting diabetes drug Bydureon.

FORBES: The Bull Case For MannKind's Insulin Inhaler

Roche is developing a similar, long-acting GLP-1 drug, and it might face similar problems.

FORBES: Dark Cloud Over Amylin

This is surprising because Bydureon is a long-acting version of an already approved drug, Byetta.

FORBES: Why FDA Communications Must Be Public